Fig. 1From: Evaluation of polydentate picolinic acid chelating ligands and an α-melanocyte-stimulating hormone derivative for targeted alpha therapy using ISOL-produced 225AcLigand structures discussed in this work: macrocyclic commercial standard DOTA, previously reported ligands macropa and H2bispa2, acyclic picolinic acid “pa” ligands p-NO2-Bn-H4neunpa, H6phospa, H4CHXoctapa, and H4octapa, and DOTA-CycMSH bioconjugate (CCZ01048)Back to article page